BioForce Nanosciences swings to quarterly net income of $238,682; posts no revenue in Q2 FY26

• BioForce Nanosciences Holdings swung to net income of USD 238,682 in the quarter ended June 30, 2026, from a net loss a year earlier.
• Operating expenses climbed to USD 262,330 from USD 122,781, driven by higher board compensation and general and administrative costs.
• Revenue was nil in the quarter, with no supplement orders and no oil and gas production.
• BioForce shifted its business model to oil and gas on June 5, receiving assigned federal leases covering about 19,957 acres in Nye County, Nevada.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioForce Nanosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001091818-26-000108), on August 10, 2026, and is solely responsible for the information contained therein.